“Single-Injection Intravitreal Bevacizumab Versus bevacizumab–triamcinolone for Diabetic Macular Edema: A Prospective Comparative Observational Study Evaluating Efficacy, Durability and Intraocular Pressure Safety During 12 Weeks of Follow-Up”. SJ Ophthalmology Africa, vol. 3, no. 3, July 2026, p. 9, https://doi.org/10.51168/w9sfw022.